New publications in health economics and genomics 19th January 2021

Two publications from the past week:

  • Valuing genetic and genomic testing in France: current challenges and latest evidence | link
  • The ethics of genomic medicine: redefining values and norms in the UK and France | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 12th January 2021

Two publications from the past week:

  • Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History | link
  • Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS) | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 5th January 2021

Happy new year everybody. Four publications since the last update:

  • Clinical utility of genomic sequencing: a measurement toolkit | link
  • Economic impact of medical genetic testing on clinical applications in Thailand | link
  • Exome Sequencing for Isolated Congenital Hearing Loss: A Cost‐Effectiveness Analysis | link
  • Comprehensive genomic profiling for non-small-cell lung cancer: health and budget impact | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New Journal Special Issue Announced

The Journal of Community Genetics has just announced a new Special Issue titled “Resource Allocation in Genomic Medicine”. I will be guest editing this Special Issue with Dr Ilias Goranitis (University of Melbourne) and Ingrid Slade (University of Oxford; Head of Public Health, Wokingham Borough Council).

The Special Issue will focus on the issues surrounding resource allocation in genomic medicine from a variety of perspectives. Articles should aim to explore and describe best practice in resource allocation in this context and highlight key challenges, particularly those that are generalizable internationally.

Contributions are invited on, but not restricted to, the following themes:

  • Valuing genomic tests – challenges in the health technology assessment process;
  • Ethical, legal and social issues associated with resource allocation in genomic medicine;
  • The role of patients in resource allocation decision making in genomic medicine;
  • Commissioning genomic services within health systems;
  • Policy issues surrounding the translation of genomic medicine into clinical practice;
  • Resource allocation issues related to genomic testing in primary care and the wider community;
  • Resource allocation issues related to implementing genomic medicine in low- and middle-income countries;
  • Incorporating the wider economic impacts of genome sequencing in resource allocation decisions.

The deadline for submissions is 1st March 2021, and the Special Issue will be published in summer 2021.

Full details available here. Any questions, don’t hestiate to drop either me or Ilias an email.

New publications in health economics and genomics 15th December 2020

One publication from the past week:

  • Economic Outcomes Following Combinatorial Pharmacogenomic Testing for Elderly Psychiatric Patients | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics. This is the last update before Christmas; the next update will be on Tuesday 5th January.

New publications in health economics and genomics 1st December 2020

One publication from the past week:

  • Probabilistic cost-utility analysis and expected value of perfect information for the Oncotype multigenic test: a discrete event simulation model | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 24th November 2020

Three publications from the past week:

  • Cost-Effectiveness Analysis of Biological Signature DCISionRT Use for DCIS Treatment | link
  • Evaluating the resource implications of different service delivery models for offering additional genomic findings | link
  • Implementing non-invasive prenatal testing (NIPT) in the Netherlands: An interview study exploring opinions about and experiences with societal pressure, reimbursement, and an expanding scope | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 10th November 2020

One publication from the past week:

  • A Systematic Review of the Value Assessment Frameworks Used within Health Technology Assessment of Omics Technologies and Their Actual Adoption from HTA Agencies | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 3rd November 2020

Two publications from the past week:

  • Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States | link
  • Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 27th October 2020

Five publications from the past week:

  • Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study | link
  • Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial | link
  • Measuring clinical utility in the context of genetic testing: a scoping review | link
  • Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation | link
  • Implementing Interventions with Varying Marginal Cost-Effectiveness: An Application in Precision Medicine | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics!